FindTrial
Sign In

Comparison of the efficacy related to Tramadol with Pethidine in Patients with Acute Pancreatitis: Open-label Randomized Controlled Trial

Comparison of the efficacy related to Tramadol with Pethidine in Patients with Acute Pancreatitis: Open-label Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200116006
Enrollment
44
Registered
2020-01-16
Start date
2018-11-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild pancreatitis Pain control&#44

Interventions

Strong opioid&#44
Pethidine intravenous 25&#45
50 mg intravenous q 6 hr,Weak opioid&#44
Tramadol intravenous 50 mg intravenous q 8 hr
Active Comparator Drug,Active Comparator Drug
Pethidine,Tramadol

Sponsors

Thai Gastroenterol association
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age>18 yr Diagnosis pancreatitis VAS score > 45

Exclusion criteria

Exclusion criteria: Age>80 yr CHF stage>2 Acute MI Cirrhosis ESRD GFR<30 COPD need for long term oxygen

Design outcomes

Primary

MeasureTime frame
Mean VAS score change between both drug 24 hr vas score—

Secondary

MeasureTime frame
Side effect 48 hr Side effect monitor—

Countries

Thailand

Contacts

Public ContactNatchaporn Noppacroh

Gastrointestinal department PMK

chatwithnay@hotmail.com66894506730

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026